Literature DB >> 15228828

Histopathological diagnosis and outcome of paediatric nephrotic syndrome.

Iftikhar Ejaz1, Humayun Iqbal Khan, Bushra Karim Javaid, Ghulam Rasool, Mohammad Tariq Bhatti.   

Abstract

OBJECTIVE: To determine the histological picture and outcome of treatment in cases of childhood nephrotic syndrome who needed renal biopsy.
DESIGN: An analytical study. PLACE AND DURATION OF STUDY: Department of Paediatrics, King Edward Medical College, and Mayo Hospital, Lahore from 1st June 1996 to 31st December, 2001 over a period of 5-1/2 years. SUBJECTS AND METHODS: Children suffering from nephortic syndrome who had atypical features at presentation were initially or late non-responders; frequent relapsers on < 1mg kg/day and were steroid dependent or frequently relapsed on < 1 mg kg/day but developed steroid toxicity were included. Renal biopsy was performed in these patients. Treatment was administered according to the histopathology reports. Prednisolone 60 mg /m2/day followed after response by 40 mg /m2 on alternate days (AD) which was later tapered off. In minimal change nephrotic syndrome (MCNS) with frequent relapses cyclophosphamide, cyclosporine and levimisole were used. For steroid resistant focal segmental glomerulosclerosis (FSGS) intravenous pulses of methyl-prednisolone and cyclosporine were also given. These patients were followed to see the response of the therapy.
RESULTS: The commonest diagnosis was focal segmental glomerulosclerosis (FSGS) (42%) followed by minimal change disease (MCNS) (22%), membranoproliferative or mesangiocapillary glomerulonephritis (MPGN) (14%) and Mesangioproliferative glomerulonephritis (Mes PGN) (12%). There were 6% cases of membranous nephropathy and 4% of diffuse proliferative glomerulonephritis. On presentation, 40% had hematuria, 20% were found to be hypertensive, 12% patients had renal insufficiency and in 4% C3 level was low. Majority of the patients with MPGN and FSGS had atypical features whereas none of the patients with membranous nephropathy had any of these features. Thirty percent cases each of FSGS and MCNS were responders. Among non-responders there were 4 cases of FSGS and one of MPGN.
CONCLUSION: FSGS was the commonest histology in cases of childhood nephrotic syndrome that needed renal biopsy. Highest frequency of atypical features was seen in MPGN and FSGS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228828     DOI: 04.2004/JCPSP.229233

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

1.  Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome.

Authors:  Zhuwen Yi; Zhihui Li; Xiao-Chuan Wu; Qing-Nan He; Xi-Qiang Dang; Xiao-Jie He
Journal:  Pediatr Nephrol       Date:  2006-05-06       Impact factor: 3.714

2.  Pathological profile of biopsied Egyptian children with primary nephrotic syndrome: 15-year single center experience.

Authors:  Ashraf Bakr; Riham Eid; Amr Sarhan; Ayman Hammad; Ahmed Mahmoud El-Refaey; Atef El-Mougy; Mohammed Magdy Zedan; Fatma Moustafa; Ashraf Abdelrahman
Journal:  J Nephrol       Date:  2014-01-16       Impact factor: 3.902

3.  Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome.

Authors:  Zhihui Li; Cuirong Duan; Jinhua He; Tianhui Wu; Mai Xun; Yi Zhang; Yan Yin
Journal:  Pediatr Nephrol       Date:  2009-12-02       Impact factor: 3.714

4.  Histopathological spectrum of childhood nephrotic syndrome in Pakistan.

Authors:  Muhammed Mubarak; Ali Lanewala; Javed Iqbal Kazi; Fazal Akhter; Atika Sher; Amir Fayyaz; Sajid Bhatti
Journal:  Clin Exp Nephrol       Date:  2009-07-28       Impact factor: 2.801

5.  Treatment of steroid and cyclosporine-resistant idiopathic nephrotic syndrome in children.

Authors:  A A Nikibakhsh; H Mahmoodzadeh; M Karamyyar; S Hejazi; M Noroozi; A A Macooie
Journal:  Int J Nephrol       Date:  2011-09-22

6.  Comment on "Ten-year experience of pediatric renal biopsies from a single center in Pakistan".

Authors:  M Mubarak
Journal:  Indian J Nephrol       Date:  2012-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.